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Abstract  Originally composed of the single family Chlamydiaceae, the Chlamydiales order has 1 extended considerably in the last decades. Chlamydia-related bacteria were added and 2 classified in 6 different families and family-level lineages: the Criblamydiaceae, 3 
Parachlamydiaceae, Piscichlamydiaceae, Rabdochlamydiaceae, Simkaniaceae and 4 
Waddliaceae. While several members of the Chlamydiaceae family are known pathogens, 5 recent studies showed diverse associations of Chlamydia-related bacteria with human and 6 animal infections. Some of these latter bacteria are preoccupying since, given their ability to 7 replicate in free-living amoebae, they may also replicate efficiently in other phagocytic cells, 8 including cells of the innate immune system. Thus, a new Chlamydiales-specific real-time 9 PCR targeting the conserved 16S rRNA gene was developed. This new molecular tool can 10 detect at least 5 DNA copies and show very high specificity without cross-amplification 11 from other bacterial clade DNA. The new PCR was validated with 128 clinical samples 12 positive or negative for Chlamydia trachomatis or C. pneumoniae. Among 65 positive 13 samples, 61 (93.8%) were found positive with the new PCR. The 4 discordant samples, re-14 tested with the original test, were negative or below detection limits. Then, the new PCR 15 was applied to 422 nasopharyngeal swabs taken from children with and without 16 pneumonia: 48 (11.4%) samples were positive, of which 45 were successfully sequenced. 17 The majority of the sequences corresponded to Chlamydia-related bacteria and especially to 18 members of the Parachlamydiaceae family.19 
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 20 
INTRODUCTION 21 The Chlamydiales order contains obligate intracellular bacteria separated in 7 different 22 families and family-level lineages, the Chlamydiaceae, the Criblamydiaceae, the 23 
Parachlamydiaceae, the Piscichlamydiaceae, the Rhabdochlamydiaceae, the Simkaniaceae 24 and the Waddliaceae (16, 23-25). Some of these bacteria are established pathogens and for 25 instance, Chlamydia trachomatis, C. psittaci and C. pneumoniae from the Chlamydiaceae 26 family can cause significant human infections. The others families constitute a group called 27 
Chlamydia-related bacteria (also referred as Chlamydia-like organisms), which has been yet 28 poorly investigated. Like the Chlamydiaceae, these Chlamydia-related bacteria are obligate 29 intracellular bacteria that also exhibit a biphasic developmental cycle. Serological and 30 molecular studies have implicated some species in various human and animal infections. 31 
Parachlamydia acanthamoebae is associated with human pneumonia (6, 12, 26, 27) and 32 might cause bovine abortions (5, 38, 39), Simkania negevensis is responsible of respiratory 33 infections, especially in children (18, 20, 22, 28, 32-35) whereas Waddlia chondrophila has 34 been reported to cause abortion in bovines (14, 40) and is strongly suspected as an agent of 35 miscarriage in human (3, 4). Some of these newly discovered Chlamydia-related bacteria 36 that resist digestion by several environmental amoebae are also resistant to professional 37 phagocytes of the innate immune system such as macrophages. Considering their potential 38 threat on human health, it is important to be able to detect these obligate intracellular 39 bacteria, since classical culture methods are ineffective. Thus, quantitative real-time PCRs 40 have been developed (6, 21, 26, 31, 42), however they target specifically only one single 41 species. Moreover, the only “broad-range” quantitative real-time PCR previously developed 42 
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in the field is a family-specific PCR amplifying DNA from members of the Chlamydiaceae 43 family, which will not allow detection of Chlamydia-related bacteria (17). Since the 44 biodiversity of Chlamydiales appears to be much larger than previously expected and new 45 chlamydial strains are constantly discovered (7-9, 29, 30, 41), a molecular diagnostic tool 46 able to detect any member of the Chlamydiales order is needed. Such a molecular tool would 47 help in identifying the potential pathogenic role of Chlamydia-related bacteria and in 48 specifying the true diversity of Chlamydiales, which is likely yet underestimated. 49 Thus, we developed a Chlamydiales-specific real-time Taqman PCR (hereafter named pan-50 
Chlamydiales PCR), that we validated using 128 clinical samples available from previous 51 studies. We also applied this new PCR to 422 nasopharyngeal swabs samples taken from 52 children with and without pneumonia, to investigate for the presence of chlamydial DNA. 53  54 MATERIAL AND METHODS 55 
DNA extraction. Nasopharyngeal swabs samples were extracted automatically with the LC 56 automated system (Roche, Rotkreuz, Switzerland) and the MagNA Pure LC DNA isolation kit 57 I (Roche). Extracted DNAs were re-suspended in 100 µl of the provided elution buffer. One 58 negative extraction control was included for each extraction run (32 wells/extraction run). 59 
Primers and probe. Based on an alignment of the 16S ribosomal RNA sequences available 60 in Genbank database (http://www.ncbi.nlm.nih.gov/genbank/), specific primers and probe 61 were designed using the Geneious software 5.0.3 and primer3Plus (37). Locked Nucleic 62 Acids (underlined below) were added to ensure a higher specificity. We chose a primer 63 forward panCh16F2 (5’-CCGCCAACACTGGGACT-3’), a primer reverse panCh16R2 (5’-64 GGAGTTAGCCGGTGCTTCTTTAC-3’) and a probe panCh16S (5’-FAM [6-carboxyfluorescein]-65 
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CTACGGGAGGCTGCAGTCGAGAATC-BHQ1 [Black Hole Quencher]-3’), targeting a fragment 66 of about 207 to 215 bp in the 16S ribosomal RNA gene (length variable according to the 67 species). 68 
Real-time PCR assay. PCR assays were performed in 20 µl, with iTaq supermix with ROX 69 (BioRad, Reinach, Switzerland), 0.1 µM of each primer (Eurogentec, Seraing, Belgium), 0.1 70 µM of probe (Eurogentec), molecular biology grade water (Sigma-Aldrich, Buchs, 71 Switzerland) and 5 µl of DNA sample. Cycling conditions were 3 min at 95°C, followed by 50 72 3-steps cycles of 15 s at 95°C, 15 s at 67°C and 15 s at 72°C. PCR products, tested in 73 duplicate, were detected with a StepOne instrument (Applied Biosystems, Zug, Switzerland) 74 for children nasopharyngeal swabs and with a ABI 7900 (Applied Biosystems) for analytic 75 validation on samples from the retrospective study. Water was used as a negative PCR 76 control.  77 
Quantification and positive recombinant plasmid control. DNA from Parachlamydia 78 
acanthamoebae strain Hall’s coccus was isolated from a purified bacterial culture available 79 in our laboratory, using the Wizard Genomic DNA purification kit (Promega, Duebendorf, 80 Switzerland). A PCR reaction was performed using the polymerase AmpliTaq Gold (Applied 81 Biosystems) and the primers Pacstd16SF2 (5'-GCTGACGGCGTGGATGAGGC-3') and 82 Pacstd16SR2 (5'-CCTACGCGCCCTTTACGCCC-3'). The PCR products were purified with the 83 MSB Spin PCRapace kit (Invitek, Berlin, Germany) and cloned according to the 84 manufacturer’s protocol, in the pCR2.1-TOPO vector (Invitrogen, Basel, Switzerland) 85 containing ampicilin and tetracycline resistance genes. Isolation of plasmidic DNA was 86 performed with the QIAprep Spin Miniprep Kit (Qiagen, Kombrechtikon, Switzerland). The 87 construction was checked by sequencing, using primers of the pCR2.1-TOPO vector 88 
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provided in the kit. Quantification of the recombinant plasmid was done on a Nanodrop ND-89 1000 (Witech, Littau, Switzerland), and serial dilutions (105 to 100 copies/µl) were used as 90 positive controls, to establish a standard curve for quantification and to check the 91 reproducibility and efficiency of detection (see below). Negative controls, standard curve 92 and samples were all analyzed in duplicate.  93 
Analytical specificity, efficiency and reproducibility of the PCR 94 The specificity of the new quantitative PCR was tested using DNA extracted from different 95 bacteria commonly found in respiratory tract samples (Table 1). DNAs were diluted at 105 96 copies of the 16S rRNA gene per reaction. Using the positive control plasmid, the analytical 97 sensitivity and the reproducibility of the PCR was assessed on duplicates with 10-fold 98 dilutions (5x105 to 5x100 copies/reaction) in 12 independent runs. The efficiency of 99 detection was performed with the positive control plasmid diluted at 50, 20, 5, 1 and 0.5 100 DNA copies per reaction; each concentration tested in 20 replicates. The range of the PCR 101 was also evaluated with chlamydial DNA from 15 different strains (Table 2). 102 
Clinical samples. The new pan-Chlamydiales PCR was validated on 128 clinical samples. 103 Different clinical samples including urines, cervico-vaginal, anorectal and nasopharyngeal 104 swabs were collected and DNA was extracted between 2004 and 2010 by the diagnostic 105 laboratory of the Institute of Microbiology, Lausanne, Switzerland (Table 3). These samples 106 were originally tested with a real-time PCR specific of Chlamydia trachomatis (113 samples) 107 (2, 13) and with a multiplex real-time PCR (42) detecting specifically Chlamydia 108 
pneumoniae but also Mycoplasma pneumoniae and Legionella pneumophila (15 samples). 109 Positive samples for M. pneumoniae (5 samples) or L. pneumophila (3 samples) were 110 included to confirm the high specificity of the new real-time PCR. We then applied our new 111 
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pan-Chlamydiales PCR to 422 nasopharyngeal swabs prospectively collected between 2008 112 and 2010 at the University Hospitals of Geneva from children with (n=265) or without 113 (n=157) pneumonia. Pneumonia was defined by the presence of at least one of the 114 following symptoms: fever (>38°C), cough, dyspnea, tachypnea and an infiltrate or a 115 consolidation at the lung X-ray. All samples were systematically tested for the following 116 viruses by PCR: respiratory syncytial virus A, B, adenovirus A, B, C and E, coronavirus 117 HKU1, OC43, 229E, NL63, parainfluenzae virus 1, 2 and 3, HMPV A, B, enterovirus A, B, C, D, 118 rhinovirus A, B, influenza virus A, B and H1N1 for some samples during the 2009 epidemics. 119 In addition, the nasopharyngeal samples were tested by PCR for the presence of 120 
Streptococcus pneumoniae and by real-time PCR for Mycoplasma pneumoniae and Legionella 121 
pneumophila. Children were aged between 1 and 15 years old: median age in the group of 122 pneumonia was 4.6 years old and 6.2 years old for the control group. All DNA samples were 123 tested in duplicate. Positive samples were systematically confirmed in a second run. To test 124 for potential false negative results due to PCR inhibitors, an inhibition test was 125 systematically performed with 4 µl of clinical DNA samples and 1 µl of the positive control 126 at a concentration of 200 DNA copies/µl. The PCR was considered inhibited when the 127 quantification was below 50 DNA copies per reaction (four-fold reduction). Moreover, a 128 total of 60 non inoculated swabs (Copan, Brescia, Italy) were used as an additional negative 129 control, to check that the commercial swabs used in the prospective study were not 130 contaminated with any chlamydial DNA. 131 
Sequencing of positive samples. Amplicons of positive samples were purified using the 132 MSB Spin PCRapace kit (Invitek). A sequencing PCR was performed with specifically 133 designed inner primers panFseq (5’-CCAACACTGGGACTGAGA-3’) and panRseq (5’-134 
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GCCGGTGCTTCTTTAC-3’). The sequencing PCR assay was done using the BigDye® 135 Terminator v 1.1 Cycle seq kit (Applied Biosystems). Sequences of positive nasopharyngeal 136 samples taken from children have been deposited on the NCBI website. Accession numbers 137 are HQ721193 to HQ721240. 138  139 RESULTS 140 
Sensitivity and specificity of the pan-Chlamydiales quantitative PCR  141 No cross-reaction was observed with the different bacterial or amoebal strains tested 142 (Table 1). A competition test was also performed by testing an increasing amount of DNA 143 from Protochlamydia naegleriophila strain KNic (from 0 to 103 copies of the 16S rRNA gene 144 per reaction) in the presence of an increasing amount of a mixture of non chlamydial DNA 145 (Table 1) (from 0 to 106 copies of the 16S rRNA gene per reaction). The amplification of the 146 DNA from P. naegleriophila strain KNic was not affected by competing non chlamydial DNA 147 up to 105 copies of the 16S rRNA gene of non targeted bacteria, demonstrating the high 148 specificity of the PCR. The range of the new PCR was evaluated with 15 DNAs from different 149 chlamydial strains (Table 2). As expected, all the different members of the Chlamydiales 150 order tested were detected, confirming the large range of the PCR. Despite the presence of 1 151 mismatch with the probe in the 16S rDNA sequence of C. psittaci and C. abortus, both 152 species were successfully amplified. Alignment of all other sequences available from 153 members of the Chlamydiales order demonstrated that 1 mismatch is also present for C. 154 
caviae, C. felis, and Candidatus Clavochlamydia salmonicola in the probe or for 155 
Rhabdochlamydia porcellionis and R. crassificans in the forward primer. These species are 156 nevertheless likely all amplified with our new pan-Chlamydiales PCR. Indeed, numerous 157 
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DNAs somehow related to Rhabdochlamydiaceae have been successfully amplified from 158 clinical samples (see below). The only known member of the Chlamydiales order likely not 159 amplified using our pan-Chlamydiales PCR is Piscichlamydia salmonis, since as many as 6 160 mismatches are present 161 
Reproducibility and efficiency of the pan-Chlamydiales real-time PCR 162 The inter-run and intra-run reproducibility was assessed respectively on 12 independent 163 runs and 72 duplicates, which results are shown in Figure 1 (A and B). All duplicates were 164 amplified for 50 and more DNA copies per reaction and 18 replicates out of 24 (75%) for 5 165 DNA copies per reaction. The Bland-Altman graph clearly indicates that differences 166 between duplicates were below 1 cycle threshold (Ct) for DNA copies above 50 per 167 reaction, demonstrating a high reproducibility. The efficiency of detection was evaluated on 168 20 replicates for 50, 20, 5, 1 and 0.5 DNA copies per reaction. The PCR showed 100% 169 detection for 50 and 20 DNA copies, 75%, 30% and 5% for 5, 1 and 0.5 DNA copies per 170 reaction respectively (Fig. 1C). 171 
Analytical validation of the new PCR 172 Over the 65 samples positive for Chlamydia trachomatis or C. pneumoniae, 61 (93.8%) 173 samples were found positive with the new PCR (Table 3A and B). The 4 discordant samples 174 were originally positive for C. trachomatis, from anorectal swabs (n=2), urine (n=1) and 175 ascitis liquid (n=1). These 4 samples were tested a second time with the original test (C. 176 
trachomatis real-time PCR) and were found negative (n=1) or positive with only 0.2, 6 and 177 1.2 copies per reaction, which was most certainly below the detection limits of the pan-178 
Chlamydiales PCR. Seven positive samples with the pan-Chlamydiales PCR (cycle threshold 179 values from 23.6 to 41.3) were sequenced to confirm the results. All the sequences obtained 180 
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showed 100% similarity with the expected species (Supplementary table S1), confirming 181 the specificity of the new PCR and the possible identification by sequencing even with later 182 cycle threshold values. Positive samples for Mycoplasma pneumoniae (n=5) and Legionella 183 
pneumophila (n=3) were all found negative with the new PCR (Table 3A). On the total of 63 184 samples negative for C. trachomatis or C. pneumoniae, only 1 sample was amplified, showing 185 92% with the closest previously described Protochlamydia naegleriophila strain CRIB 41 186 (FJ532294.1) (Table 3B).  187 
Application of the quantitative PCR  188 The application of the new pan-Chlamydiales PCR was on 422 nasopharyngeal swabs 189 samples taken from children revealed 48 positive samples: 31 (7.3%) samples with 1/4 190 positive wells, 6 (1.4%) samples with 2/4 positive wells, 4 (0.9%) samples with 3/4 191 positive wells and 7 (1.7%) samples with 4/4 positive wells (Supplementary Table S2). A 192 correlation between the cycle threshold value (Ct) and the number of positive wells was 193 observed (Supplementary figure S1). Samples with <5 DNA copies per reaction (high Ct 194 values) were amplified in 3/4, 2/4 and 1/4 wells. The 48 positive samples were sequenced 195 and 48 sequences were obtained from 45 different patients (Supplementary Table S2). 196 Indeed, the sequencing of 3 samples failed and for 3 others samples, 2 different sequences 197 were obtained (Patients GE10169, HE210023, HE210045, see Table S2). Thus 94% of the 198 positive samples were successfully sequenced. Patients’ characteristics and sequencing 199 results for patients with pneumonia are presented in Table 4. Among these 25 patients 200 listed in Table 4, another etiology was identified for only 8 patients.  201 A percentage of similarity for the best BLAST greater than 90% was observed for all the 48 202 sequences obtained, allowing identification at least at the family level. On the 48 sequences 203 
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obtained, 26 belonged to the Parachlamydiaceae family, 7 to the Chlamydiaceae family, 5 to 204 the Simkaniaceae family, 5 to the Criblamydiaceae family, 3 to the Rhabdochlamydiaceae 205 family, 1 seemed to belong to the novel E6-lineage (7, 11) and 1 other sequence 206 corresponded to an unclassified Chlamydiales (Table S2). Among the 7 sequences 207 corresponding to a Chlamydiaceae species, 6 showed 100% similarity with Chlamydia 208 
pneumoniae: 5 samples were taken from children with pneumonia (Table 4) whereas 1 was 209 taken from an apparently healthy child (Supplementary Table S2). This latter patient had a 210 previous history of obstructive bronchitis and chronic otitis media. The remaining 211 
Chlamydiaceae sequence showed 100% similarity with C. trachomatis (the sample was 212 taken from a child with pneumonia) (Table 4). Among the 26 sequences corresponding to a 213 member of the Parachlamydiaceae family, 10 (40%) were taken from 10 patients with 214 pneumonia and 16 (60%) from 15 patients from the control group (patient HE210023 215 being positive for 2 different bacteria). These latter patients were positive in 4/4, 3/4, 2/4 216 and 1/4 positive wells, respectively for 2, 2, 3 and 18 nasopharyngeal swabs (Table S2). 217 
Criblamydiaceae species were recovered from 4 patients with pneumonia (all with 1/4 218 positive well) and 1 patient from the control group (4/4 positive wells). Simkaniaceae 219 species were found in 5 patients (3 control patients and 2 children with pneumonia). 220 Finally, Rhabdochlamydiaceae species were identified in 1 case of pneumonia and 2 control 221 subjects. Thus, 17 and 20 children with and without pneumonia respectively, were positive 222 for a Chlamydia-related bacterium. In addition, a sample taken from a control subject could 223 not be affiliated in any range of family-level lineage (unclassified Chlamydiales).  224 All 60 non inoculated Copan swabs were found negative with the pan-Chlamydiales PCR, 225 demonstrating that the positive samples were not false positive. Furthermore, no absence 226 
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of the internal amplification control was observed, excluding false negative results due to 227 PCR inhibitors. 228 
 229 DISCUSSION 230 In this work, we developed a new Chlamydiales-specific PCR that proves to be specific to the 231 
Chlamydiales order, to be sensitive for at least 5 DNA copies per reaction of the positive 232 control (with an efficiency of 75%) and to be highly reproducible. Moreover, its application 233 to clinical samples taken from children with and without pneumonia demonstrated the 234 common exposure of humans to various Chlamydia-related bacteria. This new PCR showed 235 a broad range of targeted species since it detected the 15 different chlamydial strains tested 236 and the DNAs of 36 never described species-level lineages (<97% similarity of the 16S 237 rDNA sequence) of the Chlamydiales order (>80% similarity of the 16S rDNA sequence) 238 (16, 25) present in nasopharyngeal swabs samples (Supplementary Table S2). Furthermore, 239 this new PCR could detect chlamydial DNA from samples of various origins (Table 3).  240 Previous classical pan-Chlamydiales PCRs have already been developed (10, 36, 43) but they 241 detected from 1000 DNA copies compared to real-time PCRs that can detect about 200 to 242 1000-fold less DNA copies per reaction. This higher sensitivity is likely due to the shorter 243 reads (about 200 bp) and the read-out thank to a fluorescent Taqman probe. Considering 244 this high sensitivity, DNA extraction, real-time PCR and sequencing reactions were 245 processed in separate rooms to avoid contaminations between samples. In addition, 246 automated DNA extraction located outside from our research laboratory was preferred. 247 Moreover, since no sequence obtained showed more than 97% similarity with bacteria 248 grown in our laboratory, a contamination may not explain the obtained results. The 249 
12 
 
sequencing of most positive samples was possible and results were informative at the 250 family-level. A previous study using short sequences of Chlamydiales also successfully 251 identified strains at the family-level with similar length sequences (140 to 195 bp) (43). 252 Further identification, at the species-level, may be performed using complementary 253 methods (PCR targeting a more discriminative core gene such as rpoB or gyrA). 254 As previous studies on nasal and/or nasopharyngeal samples have already allowed the 255 recovery of Chlamydia-related bacteria or the amplification of DNA of these obligate 256 intracellular bacteria (1, 12, 15, 36), we chose similar samples for the first application of the 257 new PCR. The sequencing results on these nasopharyngeal swabs confirmed previous 258 studies on the occurrence of Chlamydia-related bacteria in nasal mucosa of healthy 259 individuals (1). They also clearly showed that the biodiversity of Chlamydia-related bacteria 260 is far from being established: among the 48 sequences, 36 were from putative new species, 261 when considering the Everett cut-off of < 97% 16S rRNA similarity to define species-level 262 lineages and all were belonging to the Chlamydiales order (>80% similarity of the 16S rDNA 263 sequence) (16, 23, 24). Thus, our work clearly demonstrates the common exposure of 264 children to different Chlamydiales, since around 11.4% of patients were positive with the 265 new PCR. When a Chlamydiaceae species was amplified, it was generally from a sample 266 taken from a child with pneumonia (6/7). Noteworthy, DNA of Criblamydiaceae were also 267 mainly amplified from patients with pneumonia (4/5), whereas other Chlamydia-related 268 bacteria were amplified from nasopharyngeal swabs taken from both children with and 269 without pneumonia. Thus, although our study demonstrated a common exposure to 270 
Parachlamydiaceae, (amplified from 5.9% of all samples), these were not over-expressed in 271 the pneumonia group.  Nonetheless, since the sequencing does not allow identification at 272 
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the species level, a significant correlation with a given species may not be excluded. 273 Similarly, our work did not bring any argument in favor of an association of Simkaniaceae 274 with pneumonia in children. This was somehow expected, since initial studies that 275 suggested an association of Simkania negevensis with diverse respiratory infections in 276 children (15, 18-20, 22, 32, 33, 35) were not confirmed in more recent works (34). Further 277 research is now needed to specify the pathogenic role of each representing species in the 278 
Chlamydiales order.  279 
In conclusion, this work provides a new diagnostic approach to specify the biodiversity and 280 pathogenic role of Chlamydia-related bacteria and highlights the common exposure of 281 children to Parachlamydiaceae.282 
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 415 Figure 1: Reproducibility and efficiency of the new real-time PCR. Inter and intra-run 416 reproducibility was performed between 12 different runs representing 72 duplicates of 417 positive control. (A) Inter-run variability. (B) Bland-Altman graph represents the intra-run 418 variability between duplicates and a bias of 0.36 was calculating as well as the 95% limit of 419 agreement shown by the dashed line. (C) Efficiency was evaluated with 20 replicates of 5 420 different plasmid control concentration (50, 20, 5, 1 and 0.5 copies per reaction). 421 
Supplementary figure S1: the graph shows cycle threshold (Ct) values according to the 422 percentage of positive wells obtained for nasopharyngeal samples. The dashed line 423 represents the mean Ct (36.3) obtained for 24 replicates of 5 DNA copies of the positive 424 plasmid control per reaction (Fig.1A). The majority of clinical samples were detected at Ct 425 values >36.3, corresponding to <5 DNA copies per reaction, for which the efficiency of the 426 PCR decreases. 427 
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 428 
Table 1: Bacterial and amoebal species used to test the specificity. 429 
BACTERIAL SPECIES Source/strain 
Bacteroides fragilis* ATCC25825 
Escherichia coli* ATCC 25922 
Haemophilus influenzae* ATCC 49247 
Legionella pneumophila Clinical specimen 
Mycoplasma pneumoniae Clinical specimen 
Pseudomonas aeruginosa* ATCC 27853 
Staphylococcus aureus* ATCC 25923 
Streptococcus mitis ATCC 6249 
Streptococcus pneumoniae* Clinical specimen AMOEBAL SPECIES Source/strain 
Acanthamoeba castellanii ATCC 30010 
Acanthamoeba comandoni Strain WBT 
Dictyostelium discoideum DH1-10 
Hartmannella vermiformis ATCC 50237  *Bacterial DNA used in the competition test with Pr. naegleriophila strain KNic.430 
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 431 
Table 2: Chlamydial DNA used to evaluate the range of the new PCR 432 
Chlamydial species Source/strain 
Chlamydia abortus  Strain S26/3a 
Chlamydia pecorum Strain W73 b 
Chlamydia pneumoniae Strain K6 c 
Chlamydia psittaci  Strain T49/90 d 
Chlamydia suis Strain S45/6a 
Chlamydia trachomatis Clinical specimen 
Criblamydia sequanensis Strain CRIB-18 
Estrella lausannensis Strain CRIB-30 
Neochlamydia hartmannellae ATCC 50802 
Parachlamydia acanthamoebae  Strain Hall’s coccus 
Parachlamydia acanthamoebae  ATCC VR-1476 (strain Bn9) Candidatus Protochlamydia amoebophila  ATCC PRA-7 (strain UWE25) 
Protochlamydia naegleriophila  Strain KNic 
Simkania negevensis ATCC VR-1471 
Waddlia chondrophila ATCC VR-1470 a Kindly provided by G.E. Jones, Moredun Research Institute, Edinburgh, UK 433 
b Kindly provided by J. Storz, Baton Rouge Louisiana, LA, USA 434 
c Kindly provided by A. Pospischil, Zürich, Switzerland 435 
d Kindly provided by R.K. Hoop, Zürich, Switzerland 436 
437 
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Table 3: Analysis of samples from various origins by the pan-Chlamydiales PCR in 438 comparison with the C. pneumoniae PCR (A) and the C. trachomatis PCR (B). 439 
A 440  C. pneumoniae Pan-Chlamydiales Samples + - + - Nasopharyngeal swabs 1 1 1/0 1 1 Bronchoalveolar lavages 0 6 2/1 0 6 Bronchial aspirates 0 4 0/2 0 4 Sputa 1 2 2/0 1 2 Sub-total 2 13 2 13 Total 15 15 Superscript numbers indicate the number of positive sample for Mycoplasma pneumoniae 441 and the number of positive sample for Legionnella pneumophila (M.pn./L. pn.), respectively 442 B 443  C. trachomatis Pan-Chlamydiales Samples + - + - Vaginal or cervical swabs 14 15 14 15 Anorectal swabs 14 0 12 2** Urethral swabs 1 0 1 0 Eye swabs 1 1 1 1 Urines 32 33 31(+1°) 32(+1*) Ascitis liquid 1 1 0 2* Sub-total 63 50 60 53 Total 113 113 
 444 * 1 or **2 sample(s) positive for C. trachomatis but negative with the pan-Chlamydiales PCR; 445 ° 1 sample negative for C. trachomatis but positive with the pan-Chlamydiales PCR. 446 
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Table 4: Sequencing results of nasopharyngeal samples from the pneumonia group positive with the new pan-Chlamydiales 447 PCR 448 Patient no. Sex Age (years) Signs and symptoms Other etiology Underlying condition(s) % 16S rRNA gene homology with most similar GenBank sequence (corresponding family) GE10160 F 3.7 39.0°C, cough, thoracic pain, DRS - coeliakie 100% Chlamydia pneumoniae LPCoLN (Ch) GE10097 F 2.7 40.6°C, cough, DRS - - 100% Chlamydia pneumoniae LPCoLN (Ch) VS30014 M 12.4 38.9°C, cough - - 100% Chlamydia pneumoniae LPCoLN (Ch) VS30030 F 12.2 39.5°C, cough - - 100% Chlamydia trachomatis D-LC (Ch) GE10098 F 8.0 38.0°C, cough - - 100% Chlamydia pneumoniae CWL029 (Ch) GE10014 M 7.6 39.5°C, cough M. pneumoniae - 94% Uncultured Neochlamydia sp. LTUNC09656 (P) GE10159 M 3.7 40.0°C, cough - - 100% Chlamydia pneumoniae LPCoLN (Ch) GE10169 M 5.6 40.0°C, cough, thoracic pain, tachypnea - Bronchodysplasia, premature birth (28 weeks) 97% Candidatus Rhabdochlamydia porcellionis (R) 91% Chlamydiales bacterium cvE38 (S) GE10179 F 3.6 Dyspnea S. pneumoniae H1N1 virus - Sequencing failed HE20032 M 1.5 41.6°C, cough, DRS - - 94% Uncultured Candidatus Protochlamydia sp. clone CN823 (P) VS30003 M 5.8 39.5°C, cough, DRS - - 95% Uncultured Chlamydiales bacterium clone P-5 (P) GE10027 M 9.8 38.1°C, cough, DRS M. pneumoniae asthma 92% Uncultured soil bacterium clone 530-2 (Cr) GE10036 M 1.6 38.0°C, cough, DRS, tachypnea S. pneumoniae - 95% Uncultured bacterium clone F5K2Q4C04JDDHX (P) GE10047 M 2.6  39.5°C, cough, DRS, tachypnea - - 92% Criblamydia sequanensis (Cr) GE10072 F 4.8 39.5 °C HMPV A - Sequencing failed GE10147 M 13.8 38.2°C, cough, DRS S. pneumoniae - 95% Uncultured bacterium clone FW1013-189 (P) 
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GE10193 F 5.1 38.9°C, cough, tachypnea - - 92% Chlamydiales bacterium cvE38 (S) HE20008 F 3.3 38.3°C, cough, tachypnea, DRS HUK1 - 93% Estrella lausannensis strain CRIB 30 (Cr) HE20028 F 1.1 39.5°C, cough, DRS, tachypnea HRSV A - 94% Uncultured Chlamydiales bacterium clone P-5 (P) HE20036 M 1.4 40.0°C, DRS - - 96% Chlamydiales bacterium cvE21 (E6) HE20074 M 4.5 38.1°C, cough, DRS - - 94% Criblamydia sequanensis (Cr) VS30007 M 6.6 38.7°C, cough, DRS - - 95% Candidatus Metachlamydia lacustris strain CHSL (P) VS30013 M 6.4 38.5°C, cough, tachypnea - - 94% Uncultured Chlamydiales bacterium clone P-9 (P) VS30044 M 3.8 40.4°C, cough - - 95% Uncultured Chlamydiales bacterium clone P-7 (P) VS30055 F 4.1 38.5°C, cough, tachypnea - - 92% Candidatus Metachlamydia lacustris strain CHSL (P) F= female, M = male; DRS = distress respiratory syndrome; 449 Ch= Chlamydiaceae, P = Parachlamydiaceae, R = Rhabdochlamydiaceae, S = Simkaniaceae, Cr = Criblamydiaceae, E6= novel E6-450 lineage. 451 
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Figure 1: Reproducibility and ef�iciency of the new real-time PCR. Inter and intra-run reproducibility was performed
between 12 different runs representing 72 duplicates of positive control. (A) Inter-run variability. (B) Bland-Altman
graph represents the intra-run variability between duplicates and a bias of 0.36 was calculating as well as the 95%
limit of agreement shown by the dashed line. (C) Ef�iciency was evaluated with 20 replicates of 5 different plasmid
control concentration (50, 20, 5, 1 and 0.5 copies per reaction).
 
 
Table S1: Sequencing results of 7 samples from the retrospective study positive with the 
new PCR  
Sample Sequence 
(bp) 
Threshold cycle 
(Ct) with the new 
PCR: mean ±SD 
Expected result 
of the 
sequencing 
% 16S rRNA gene sequence 
similarity with most similar 
GenBank sequence (Accession no.) 
Sputa 183 36.1 CP + 100% Chlamydia pneumoniae 
LPCoLN (CP001713.1) 
Nasopharyngeal 
swab 
183 35.5±0.7 CP + 100% Chlamydia pneumoniae 
LPCoLN (CP001713.1) 
Cervical swab 192 23.6±2.9 CT + 100% Chlamydia trachomatis D-LC 
(CP002054.1) 
Anorectal swab 151 39.0±0.2 CT + 100% Chlamydia trachomatis D-LC 
(CP002054.1) 
Urine 192 35.0±0.8 CT + 100% Chlamydia trachomatis D-LC 
(CP002054.1) 
Cervical swab 206 29.3±0.3 CT + 100% Chlamydia trachomatis D-LC 
(CP002054.1) 
Urethral swab 141 31.7±0.5 CT + 99% Chlamydia trachomatis D-LC 
(CP002054.1) 
Urine 190 41.3 CT - 94% Uncultured bacterium clone 
FW1013-189 (EF693090.1) 
CP = Chlamydia pneumoniae, CT = C. trachomatis. 
Supplementary �igure S1: the graph shows cycle threshold (Ct) values according to the percentage of positive
wells obtained for nasopharyngeal samples. The dashed line represents the mean Ct (36.3) obtained for 24
replicates of 5 DNA copies of the positive plasmid control per reaction (Fig.1A). The majority of clinical samples
were detected at Ct values >36.3, corresponding to <5 DNA copies per reaction, for which the ef�iciency of the
PCR decreases. 
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